NCT02481310 2022-02-21
Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
Northwestern University
Phase 1/2 Unknown
Northwestern University
PETHEMA Foundation
Erasmus Medical Center
Peking Union Medical College Hospital
Dutch Childhood Oncology Group
National Cancer Institute (NCI)